Clinical Trial Update: Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated prolonging comfortable wear duration of contact lenses using CLM2 topical gel; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contact Lens Acute Red Eye
• Contact Lens Discomfort
• Contact Lens-induced Corneal Disorder
• Contact Lens-induced Corneal Fluorescein Staining

Drugs mentioned

• CLM2 topical gel (CLM2 topical gel)

Snippet

Sponsor: Glia, LLC | Conditions: Contact Lens Discomfort, Contact Lens-induced Corneal Disorder | Phase 2 | Status: COMPLETED